Related Experiment Video

Updated: Jun 4, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53

Hong Wu1, Scott L Pomeroy, Manuel Ferreira

  • 1Heritage Medical Research Center, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.

Nature Medicine
|February 15, 2011
PubMed

Insights

The ubiquitination factor E4B (UBE4B) protein inactivates the p53 tumor suppressor in brain tumors. UBE4B gene amplification and overexpression are new mechanisms driving p53 loss in these cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The TP53 gene, encoding the p53 tumor suppressor, is frequently inactivated in medulloblastoma and ependymoma.
  • Loss of p53 function accelerates medulloblastoma development in mouse models.
  • Mechanisms of p53 inactivation in human brain tumors remain incompletely understood.

Purpose of the Study:

  • To investigate the role of ubiquitination factor E4B (UBE4B) in p53 inactivation in human brain tumors.
  • To identify novel molecular mechanisms contributing to p53 loss in these cancers.

Main Methods:

  • Assessed the physical interaction between UBE4B, p53, and Hdm2.
  • Evaluated the effect of UBE4B on p53 polyubiquitination, degradation, and transactivation.
  • Examined the impact of UBE4B silencing on xenotransplanted tumor growth.
  • Correlated UBE4B overexpression with p53 expression and UBE4B gene amplification in human brain tumors.

Main Results:

  • UBE4B physically interacts with p53 and Hdm2, promoting p53 polyubiquitination and degradation.
  • UBE4B inhibits p53-dependent transactivation and apoptosis.
  • Silencing UBE4B impairs tumor growth in a p53-dependent manner.
  • UBE4B overexpression correlates with decreased p53 expression and is often associated with UBE4B gene amplification in human brain tumors.

Conclusions:

  • UBE4B acts as a novel E3 and E4 ubiquitin ligase that promotes p53 inactivation.
  • UBE4B amplification and overexpression represent previously unrecognized molecular mechanisms of p53 inactivation in brain tumors.

More Related Videos

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...